We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

118 hedge funds and large institutions have $605M invested in Accelerate Diagnostics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 23

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

1% less funds holding

Funds holding: 119 → 118 (-1)

11% less capital invested

Capital invested by funds: $683M → $605M (-$78.2M)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

62% less call options, than puts

Call options by funds: $5.69M | Put options by funds: $15.2M

Holders
118
Holders Change
-1
Holders Change %
-0.84%
% of All Funds
2.94%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
18
Increased
46
Reduced
23
Closed
18
Calls
$5.69M
Puts
$15.2M
Net Calls
-$9.48M
Net Calls Change
-$7.46M

Top Buyers

1
CS
Credit Suisse
Switzerland
+$23M
2
PC
Polar Capital
United Kingdom
+$5.72M
3
EVM
Eaton Vance Management
Massachusetts
+$5.48M
4
William Blair & Company
William Blair & Company
Illinois
+$3.93M
5
KCM
Kornitzer Capital Management
Kansas
+$3.54M

Top Sellers

1
Russell Investments Group
Russell Investments Group
United Kingdom
-$7.62M
2
MGM
Miura Global Management
New York
-$5.89M
3
NIP
Nicholas Investment Partners
California
-$3.27M
4
TCM
Timpani Capital Management
Wisconsin
-$2.53M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.49M – – –
Credit Agricole
27
Credit Agricole
France
$4.23M +$2.24M +9,110 +94%
UBS Group
28
UBS Group
Switzerland
$4M +$323K +1,317 +8%
OCMI
29
Oaktop Capital Management II
New Jersey
$3.48M – – –
TCM
30
Tekla Capital Management
Massachusetts
$3.37M +$1.23M +5,000 +50%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$3.36M -$2.32M -9,441 -39%
MWNA
32
Marshall Wace North America
New York
$3.07M +$2.33M +9,481 +211%
Morgan Stanley
33
Morgan Stanley
New York
$3.06M +$182K +740 +6%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.85M -$735K -2,992 -19%
Charles Schwab
35
Charles Schwab
California
$2.77M +$155K +630 +5%
Natixis Advisors
36
Natixis Advisors
Massachusetts
$2.74M -$34.9K -142 -1%
SO
37
STRS Ohio
Ohio
$2.39M +$2.62M +10,667 New
IECM
38
Intrinsic Edge Capital Management
Illinois
$2.29M +$982K +4,000 +64%
AIM
39
Artemis Investment Management
United Kingdom
$2.25M +$2.46M +10,011 New
Jane Street
40
Jane Street
New York
$2.05M +$2.25M +9,145 New
First Trust Advisors
41
First Trust Advisors
Illinois
$1.99M +$1.09M +4,458 +101%
Goldman Sachs
42
Goldman Sachs
New York
$1.88M +$239K +974 +13%
EIM
43
Essex Investment Management
Massachusetts
$1.54M -$222K -902 -12%
TCIM
44
TIAA CREF Investment Management
New York
$1.52M -$55.3K -225 -3%
Wells Fargo
45
Wells Fargo
California
$1.5M -$158K -643 -9%
COPPSERS
46
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.46M +$1.6M +6,500 New
CI
47
Chartist Inc
California
$1.45M – – –
AFG
48
Albion Financial Group
Utah
$1.31M – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.25M – – –
GCP
50
GSA Capital Partners
United Kingdom
$1.24M +$1.36M +5,520 New
1
2
3 4 5

AXDX Hedge Fund Activity: Q3 2017 in Review

118 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2017, worth a combined $605M — down 11% from $683M a quarter earlier.

Fund positioning in AXDX was balanced in Q3 2017: 18 funds opened new positions, 18 closed out, 46 added to existing stakes and 23 trimmed.

The largest buyer was Credit Suisse, adding an estimated $23M. The largest seller was Russell Investments Group, exiting entirely with an estimated $7.62M sold.

  • 118 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2017, down from 119 in Q2 2017.
  • Funds reported $605M of Accelerate Diagnostics stock for Q3 2017, down 11% quarter-over-quarter.
  • 18 funds opened new Accelerate Diagnostics positions in Q3 2017 and 18 closed out, a net change of 0 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2017 was Credit Suisse, an estimated $23M added.
  • The largest Accelerate Diagnostics seller in Q3 2017 was Russell Investments Group, an estimated $7.62M sold.

Based on aggregated 13F filings for Q3 2017.